http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104974154-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
filingDate 2014-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104974154-B
titleOfInvention Hirsutine analogue and application thereof in preparation of anti-hypertensive drugs
abstract The invention belongs to the field of traditional Chinese medicine production and relates to a traditional Chinese medicine uncaria extract, namely hirsutine analogue compound with the structure represented by formula (1) and application of the hirsutine analogue compound in the preparation of anti-hypertensive drugs. An experiment proves that the hirsutine analogue compound has remarkable pharmacological actions of resisting hypertension and vascular dilation. A spontaneously hypertensive rat (SHR) experiment proves that the blood pressure and the heart rate of an SHR are obviously decreased after 30 minutes of administration, and the blood pressure of the spontaneously hypertensive rat can be rapidly and effectively decreased; an in-vitro vascular ring vasomotion experiment proves that by virtue of an extremely low dose of the hirsutine analogue compound, the vascular ring contraction caused by phenylephrine can be remarkably dilated. The hirsutine analogue compound can be used as a raw material of a pharmaceutical preparation, is further used for preparing drugs for treating hypertension and is particularly used for preparing vascular dilation drugs for treating hypertensive emergencies.
priorityDate 2014-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4528289-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134715385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5318055
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID128732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415748660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426072198
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID29802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53782903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID128732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416224594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44568160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426324436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426586969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID29802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416344866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3039336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12304085

Total number of triples: 46.